Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Receivables - Other: 2020-2023

Historic Receivables - Other for Biofrontera (BFRI) over the last 4 years, with Dec 2023 value amounting to $2.8 million.

  • Biofrontera's Receivables - Other rose 16.96% to $200,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $200,000, marking a year-over-year increase of 16.96%. This contributed to the annual value of $2.8 million for FY2023, which is 56.92% down from last year.
  • Biofrontera's Receivables - Other amounted to $2.8 million in FY2023, which was down 56.92% from $6.5 million recorded in FY2022.
  • Biofrontera's 5-year Receivables - Other high stood at $8.6 million for FY2021, and its period low was $73,000 during FY2020.
  • Moreover, its 3-year median value for Receivables - Other was $6.5 million (2022), whereas its average is $6.0 million.
  • As far as peak fluctuations go, Biofrontera's Receivables - Other soared by 11,745.21% in 2021, and later tumbled by 56.92% in 2023.
  • Biofrontera's Receivables - Other (Yearly) stood at $73,000 in 2020, then skyrocketed by 11,745.21% to $8.6 million in 2021, then decreased by 24.83% to $6.5 million in 2022, then tumbled by 56.92% to $2.8 million in 2023.